Up first, Inspirogene-by-McKesson with Joe DePinto

 

InspiroGene" is a dedicated business unit launched by McKesson in October 2024, focused solely on supporting the commercialization of cell and gene therapies (CGTs). It leverages McKesson's expertise in supply chain, logistics, and specialty pharmacy to help manufacturers, payers, and providers navigate the complex CGT landscape.

https://www.mckesson.com/business-solutions/our-businesses/inspirogene-by-mckesson/

Our featured interview:

Sponsored by MatchRX

The TrumpRx Playbook for Independent Pharmacies

CEO of MatchRx Johny Kello co-hosts with Todd Eury featuring our guest speaker, Dae Lee, Pharm.D., Esq., CPBS. Dae is a pharmacist-attorney and a Shareholder in the FDA & Biotechnology practice at Buchanan Ingersoll & Rooney. What makes Dae especially valuable for this conversation is that he’s not just reading policy from 30,000 feet — he represents pharmacies every day in high-stakes fights with PBMs, from audits and reimbursement disputes to network suspensions and terminations.

So, when we talk about TrumpRx — how it works, what it could break, and what independents should do next — Dae can translate the legal and contracting reality into real-world consequences behind the counter.

Connect with MatchRX: MatchRX.com

Special Message from Greg Reybold with APCI, update of the "Pharmacists Fight Back Act"

Connect with Greg: https://www.apcinet.com/

Next, we talk with Dr. Jessica Daley PharmD Fractional Supply Chain and Operations Executive, with Pharma Logistics, we dicuss drug shortages and strategies for 2026.

Connect with Jessica: https://www.linkedin.com/in/jessicaldaley/

Last interview, a suprise message from International Pharmacy 50 Pharmacist & Author Katrina Azer, announcing her new book  https://www.katrinaazer.com/#books

 

The TrumpRx Playbook for Independent Pharmacies - with MatchRX | TWIRx